Keywords: skyepharma, receives, cash, boost, product, enters, pivotal

SkyePharma receives cash boost as product enters pivotal trials

Article | 11 January 2001

Print This

SkyePharma of the UK will receive a $30 million injection of capitalover two years from Paul Capital Partners of the USA. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in